FY26 Full Year Results & Investor Webinar
Filed with ASX · · 5 pages · English
Summary by 6ix AI
The company achieved a notable increase in revenue and positive operating cash flow across all quarters of the year. Highlights include a substantial rise in earnings and a reduction in employee costs as a percentage of revenue, reflecting improved operational efficiency. The CEO expressed confidence in the company's strategy and provided guidance for the upcoming fiscal year, anticipating further revenue growth.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Earlier from Resonance Health
- FY26 Full Year Results & FY27 Guidance Investor Presentation
- Appendix 4E, Full Year Statutory Accounts & Annual Report
- FY26 Full Year Results Webinar
- Cessation of Quarterly Reporting
- Liver Fibrosis Device Progress & FY26 Portfolio Webinar
Later from Resonance Health
- Appendix 4G & Corporate Governance Statement
- Global Strategic Alliance & MSA with Image Analysis Group
- Change in Substantial Holding
- AGM Date & Director Nomination Closing Date
- Liver Fibrosis Device - Clinical Trial Results - Webinar
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health